“…In this facility, HUVECs were prepared from umbilical veins, as previously described (19,27). Cells were cultured in medium 199 supplemented with 20% FCS (HyClone Laboratories, Logan, UT), 16 U/ml heparin (ESI Pharmaceuticals, Cherry Hill, NJ), 50 g/ml endothelial cell growth supplement (Biomedical Technologies, Stoughton, MA), 2 mM L-glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin (Invitrogen, Carlsbad, CA), and grown at 37°C on tissue culture plates coated with 0.4% gelatin (Sigma-Aldrich, St. Louis, MO).…”